Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony-stimulating factor as support to chemotherapy for lung cancer.
Xiang JiLisheng XuPengfei PanZhiyun XuAihua WangYu LiPublished in: Thoracic cancer (2021)
ALRTI could well be prevented after prophylactic application of PEG-rhG-CSF (3 mg), and was related to the reduced neutropenia.